Risk of Alzheimer's disease gene can damage the brain in the decades before symptoms Show (HealthDay)

A gene allele that increases the risk of Alzheimer's disease began 50 years before appear it symptoms of the disease, a new study suggests brain damage.

One allele is one of two or more forms of a gene.

In 2009, scientists have concluded that the gene (EXCL) clusterin increases the chances of Alzheimer's by 16 percent, but it was not clear how it risk increased.

This new study has concluded that the c of the CLU gene allele hinders development of myelin, the protective autour axons of neurons in the brain. This violates the wiring of the brain and can make a person more susceptible to the onset of Alzheimer's disease later in life.

Approximately 88% of whites have the CLU C-allele, according to the University of California at Los Angeles (UCLA) researchers.

For this study, they have used a newer type of MRI to map the connections in the brain of almost 400 adults aged 20 to 30 years. Scans revealed that the participants with the C-allele CLU had the integrity of the white matter than those with a different variant called the CLU t allele.

The results are interesting on several levels, according to lead study author Paul Thompson, Professor of Neurology.

"For example, Alzheimer's disease has traditionally been considered a disease characterized by neuronal loss and grey generalized atrophy of matter," he said in a UCLA press release. "But degeneration of myelin in matter fiber pathways white is more be regarded as a key component of the disease and another way possible to the disease, and that supports the discovery.".

Understand the effects of the C-allele CLU could lead to ways to intervene to protect the brain in the decades before that Alzheimer's disease develops, Thompson suggested.

Public Citizen: data key left of Alzheimer's disease study (Reuters)

CHICAGO (Reuters) - a group of U.S. consumers alleged Tuesday that researchers with ties to Eli Lilly and Co withheld important information of a medical journal in their study of a drug of Imaging for Alzheimer's disease.

In a letter published in the Journal of the American Medical Association, Public Citizen criticized a study on 19 January that assessed the effectiveness of the scans of the brain to help Lilly Amyvid, dye experimental to detect abnormalities of the brain.

They said that the authors of the study excluded data on how accurately the scans have been interpreted by a doctor to another.

"Conceal important information, were induced the newspaper and its readers to believe that this test to identify abnormalities of the brain was more reliable than it actually is," Dr. Michael Carome, Director Assistant of the Public Citizen health research groupwritten.

"Given what you know of Alzheimer's disease and the lack of effective treatments, no test for the diagnosis of this disease must be proved to be very precise in studies of large, carefully before it is approved by the FDA for marketing"carome."said."

Lilly strongly dispute their claims, calling it "inaccurate."

"We have worked with the FDA to identify and specify all end points for the study of Phase III of Amyvid", the company said in a news release.

Lilly said all points of termination in the study have been met, and they have "communicated adequately."

In March, the U.S. Food and Drug Administration refused to approve Amyvid, citing the need to ensure the scans can be read accurately.

An Advisory Committee of the FDA said in January that it would take more data before approval.

Amyvid is designed to detect the plate of beta-amyloid associated with Alzheimer's disease in the brains of people living on a procedure for imaging called a computed tomography scan pet (pet).

A non-reliable test could lead some people to believe that they had Alzheimer's disease when they are not, and it could be others the false assurance that the did not have the disease, when they could, Public Citizen, said in an e-mail.

Lilly is to research the agent for use with pet market, to help doctors rule on the plate related to Alzheimer's disease, but do not to diagnose disease.

General Electric, and Bayer AG also develop rival products.

Lilly and his unit of Avid Radiopharmaceuticals have said they are trying to answer the questions raised by the FDA Advisory Committee and will continue to do so in an ongoing dialogue.

Currently, some 26 million people globally have Alzheimer's disease, the most common dementia form.

(Reported by Julie Steenhuysen.) (Editing by Laura MacInnis and Paul Simao)

Little evidence that food, lifestyle reduces risk of Alzheimer's disease

many studies have attempted to link specific behaviors and health conditions at the onset of Alzheimer's disease, but scientists still cannot say with certainty that anything do you or not do prevent brain disorder, according to a review of the U.S. of recent research.

The National Institutes of Health of the United States convened a Conference in the spring last to analyse the 18 studies of potential risks, such as poor eating habits, a chronic disease factors, smoking or small exercise and the development of Alzheimer's disease.

"Although we are not dismissing the potential role or important that these major risk factors may play in the development of Alzheimer's disease, at this time with what we have currently, we cannot confirm the associations of any risk""," says senior study author Dr. Martha l. Daviglus, Professor of preventive medicine and medicine at Northwestern University Feinberg School of Medicine in Chicago.

"If we need to do research, if we want to have the evidence in hand,", she added.

The study, which summarizes the results of the NIH Conference, is published in online may 9 and printing September issue of the Archives of Neurology.

For the moment, age is the main factor of risk known for Alzheimer's disease, the study noted. A variant of gene is also associated with an increased risk, he said.

An approximately 5.3 million Americans struggling with Alzheimer's disease, a planned figure that aging population of Baby-Boomer of the country, said the authors. The disease is responsible for between 60 and 80% of cases of dementia.

"What we are talking about here is something that will affect many Americans in the years to come," said an expert, Catherine Roe, instructor in neurology at the medical school of Washington University in St. Louis. "In fact, it will be an explosion over the next 50 years, because everyone lives in General, most" she said.

The studies included in the analysis of the NIH Research conducted between 1984 and 2009 in English. The participants were at least 50 years old and living in developed countries.

Some of the studies addressed food influences, such as the intake of folic acid, Mediterranean diet and nutritional supplements. Others find a link between the health problems, such as diabetes or high cholesterol and Alzheimer's disease. Others still explored the consumption of alcohol and physical activity levels and the risk of Alzheimer's disease.

The NIH team found that, overall, the studies has been "compromised by methodological limitations" that restrict the ability to establish a strong association between any particular health or usual behavioral condition and Alzheimer's disease.

The authors noted that these limitations result from the use of poor diagnostic criteria, low knowledge of the inner workings of Alzheimer's disease itself, or the lack of reliability of the State of physical and mental health reported the patient.

Yet, despite determining that the current quality of evidence is "insufficient" to draw cause and effect links, Daviglus and colleagues noted that the public should still focus on the ways of life that avoid behaviours already linked to other chronic diseases.

"People should follow a healthy lifestyle, which includes exercise, not control blood pressure, smoking, not become excess weight or trying to sleep properly," said Daviglus.

"And, of course, our recommendation is that it is very important that we ensure that, in the future, more well-designed comparative studies be conducted so that we can get better quality outcomes that can confirm associations, when they existententre the risk factors which have a large proportion of the population and the onset of Alzheimer's disease.""," she added.

ROE has agreed that "quality additional research is needed", but added that, "I don't think it's worse than in any other area of research." It is a difficult and stimulating work. And it costs lots of money at a time when there a crisis of funding science. ?

However, a sense of urgency should prevail, said Roe. "Now Baby Boomers are hitting the age where Alzheimer's disease comes into play," she noted. "And it will take a huge loss of life and economic toll, if we do find a way to treat or slow down." Therefore it is very important that we do more and better. ?

Little evidence that food, lifestyle reduces risk of Alzheimer's disease

many studies have attempted to link specific behaviors and health conditions at the onset of Alzheimer's disease, but scientists still cannot say with certainty that anything do you or not do prevent brain disorder, according to a review of the U.S. of recent research.

The National Institutes of Health of the United States convened a Conference in the spring last to analyse the 18 studies of potential risks, such as poor eating habits, a chronic disease factors, smoking or small exercise and the development of Alzheimer's disease.

"Although we are not dismissing the potential role or important that these major risk factors may play in the development of Alzheimer's disease, at this time with what we have currently, we cannot confirm the associations of any risk""," says senior study author Dr. Martha l. Daviglus, Professor of preventive medicine and medicine at Northwestern University Feinberg School of Medicine in Chicago.

"If we need to do research, if we want to have the evidence in hand,", she added.

The study, which summarizes the results of the NIH Conference, is published in online may 9 and printing September issue of the Archives of Neurology.

For the moment, age is the main factor of risk known for Alzheimer's disease, the study noted. A variant of gene is also associated with an increased risk, he said.

An approximately 5.3 million Americans struggling with Alzheimer's disease, a planned figure that aging population of Baby-Boomer of the country, said the authors. The disease is responsible for between 60 and 80% of cases of dementia.

"What we are talking about here is something that will affect many Americans in the years to come," said an expert, Catherine Roe, instructor in neurology at the medical school of Washington University in St. Louis. "In fact, it will be an explosion over the next 50 years, because everyone lives in General, most" she said.

The studies included in the analysis of the NIH Research conducted between 1984 and 2009 in English. The participants were at least 50 years old and living in developed countries.

Some of the studies addressed food influences, such as the intake of folic acid, Mediterranean diet and nutritional supplements. Others find a link between the health problems, such as diabetes or high cholesterol and Alzheimer's disease. Others still explored the consumption of alcohol and physical activity levels and the risk of Alzheimer's disease.

The NIH team found that, overall, the studies has been "compromised by methodological limitations" that restrict the ability to establish a strong association between any particular health or usual behavioral condition and Alzheimer's disease.

The authors noted that these limitations result from the use of poor diagnostic criteria, low knowledge of the inner workings of Alzheimer's disease itself, or the lack of reliability of the State of physical and mental health reported the patient.

Yet, despite determining that the current quality of evidence is "insufficient" to draw cause and effect links, Daviglus and colleagues noted that the public should still focus on the ways of life that avoid behaviours already linked to other chronic diseases.

"People should follow a healthy lifestyle, which includes exercise, not control blood pressure, smoking, not become excess weight or trying to sleep properly," said Daviglus.

"And, of course, our recommendation is that it is very important that we ensure that, in the future, more well-designed comparative studies be conducted so that we can get better quality outcomes that can confirm associations, when they existententre the risk factors which have a large proportion of the population and the onset of Alzheimer's disease.""," she added.

ROE has agreed that "quality additional research is needed", but added that, "I don't think it's worse than in any other area of research." It is a difficult and stimulating work. And it costs lots of money at a time when there a crisis of funding science. ?

However, a sense of urgency should prevail, said Roe. "Now Baby Boomers are hitting the age where Alzheimer's disease comes into play," she noted. "And it will take a huge loss of life and economic toll, if we do find a way to treat or slow down." Therefore it is very important that we do more and better. ?

Seth Rogen: Alzheimer's disease is "brutal".

 Seth Rogen can be known for starring in a few torrid comedies, but there is a problem, it is not taken lightly: Alzheimer's disease.

The condition crashed near the House by his future mother-in-law, which is only 59 and already has for several years. And now Rogen, who has no family history of the disease, became passionate support of the family of his fiancée and spread awareness of Alzheimer's disease.

"I think that until you can see directly, it is difficult to conceive in a brutal manner, it is," Rogen told CNN on Tuesday. "Until I saw it, you find heartbreaking type of how it may be.".

Rogen and his fiancée, Lauren Miller, previously talk with Larry King for "a Larry King special, the unthinkable: epidemic of Alzheimer's disease," which is broadcast Sundays at 8 p.m. (et).

Their story is that an example of the effects of emotional stress training introduced the disease.

"I just try to be as close as possible, also emotionally available as possible," Rogen said Tuesday CNN.

Approximately 5.4 million people in the United States suffer from Alzheimer's disease, according to the Alzheimer's Association. In the century, 16 million people should have the condition.

3 stages of Alzheimer's disease diagnosis brought

But the effect is even larger than just patients. There are caregivers non-paid nearly $ 15 million, not to mention the rest of the family and friends that tirelessly help even if no prevention, treatment or cure has been found. The disease is fatal. The average disease duration is four to eight years, although some people can live with it for 20 years.

And caregivers are providing 17 billion hours of care each year, unpaid for an annual cost of 206 billion, according to the most recent report of the Association Alzheimer.

Shriver: Nation a woman takes on Alzheimer's disease

Alzheimer's is the sixth cause of death to the United States, and one in eight Americans aged has it. The first symptoms often include problems to remember names and recent events. As the disease progresses, patient confusion was worse still, and he or she may have difficulty with basic functions such as walking, talking and swallowing. Some patients become violent, making even more difficult caregiving.

In view of the family history of bride of Rogen, the case seemed obvious when the mother of Miller began to show symptoms. Two grandparents of Miller had Alzheimer's disease. his grandfather has shown signs in his fifties. Mother of Miller was 55 years old when the family discovered that she had Alzheimer's disease.

When symptoms begin before age 65

"It would be remembered a story that I said to him, forgetting that she had spoken with someone. So it was quite clear to us what was going on, Miller told King.

Most Alzheimer's patients are aged 65 or more, but the condition can affect much earlier. Having a parent, brother or sister with the condition raises your risk of developing it yourself; both parents first degree would raise the risk. There is also a particular gene that ups the chance you will get it. None of these factors is designed, so it is difficult to predict with certainty which will develop the disease.

"The greatest misunderstanding is that it is this disease of old-people wave arrives for elderly people," says Rogen.

Rogen, who has known Miller for six years, also noted decline of his mother. It was a lot of difficulty carrying on conversations and seems if worsen even after only a few months had gone by. She had the wrong more access to words, he told King.

Medicine ineffective Alzheimer's disease for mild cases

Father Miller retired to take care of it at home. He cooks, cleans and makes his hair every morning. Miller said her mother yet known, but she is fighting with the father of Miller.

"It takes her shopping if she needs something to wear." And my father does not like shopping, Miller a. "I do not think that you are 62 years old and, you know, one day of his retirement think that you will take care of your spouse with Alzheimer's disease.

Mother of Miller does not lose his temper, but she gets so confused that she does not know why people are trying to help, the couple told King. Rogen told CNN that the mother of Miller seem to get particularly disoriented after a trip to the coast is the West Coast, so Rogen and Miller are trying to go to him instead.

Substantially with your relationship with a change of the person that he or she forgets events, information and even your name can be an emotional shock, says Beth Kallmyer, Director of customer service and information to the Alzheimer's Association.

Some people feel that they know be how to interact with an ad, and withdraw because they do not want to see their friend or relative in such a State.

But Rogen feels uncomfortable with the mother of Miller and described it as "easy to be around."

"I understand that it passes through something that I can't imagine even what it is like passing by", said Rogen.

Provide emotional support for Miller, he has also given financial assistance to his family for medical and other expenses.

Caregivers must learn about the disease and establish a support network, Kallmyer said.

Leeza Gibbons advice to caregivers: breathe, believe, receive

"You cannot do it alone." It takes too much of you. "You want to build a team of care about the disease, so that you know what to expect, she said."

Persons in a position to Rogen, who want to help but are not the primary caregiver, should know the person nearest to the patient which makes the patient happy and what makes him or her paymentKallmyer said. They should also ask directly the caregiver must more.

Generally, the caregivers have just need a break, she said. Often, something useful for a family dealing with this disease is to intervene and do something with the Alzheimer's patient, while care staff deals with issues in his own life.

She said "One of the most important things," that a caregiver can do is to ask for help.

Talk about the disease has proven useful for the Miller family, says Rogen.

"Once that you get on the instinct to not talk about, there are many people who are much more favourable that you imagine perhaps," Rogen said.

Diagnosis of Alzheimer's disease redefined

Alzheimer's disease begins long before family and friends notice differences in the patient's memory and behavior, doctors who treat the condition said Monday. By the time an official diagnosis is made, the person's function is usually significantly impaired and treatment rarely helps.

Doctors are suggesting a redefinition of Alzheimer's that would include even mild memory and behavioral symptoms. Disease experts expect an increase in the number of patients receiving the Alzheimer's diagnosis as a result of the change.

The idea, proposed by the Alzheimer's Association and the National Institutes of Health, would define Alzheimer's as a "spectrum" disease, creating three internships ranging from lesser to greater severity in hopes that the devastating neurological condition could be detected earlier.

In the U.S., 5.4 million people have an Alzheimer's diagnosis. By 2050, that number is expected to more than triple.

The aim of identifying the disease is to get patients earlier in the pipeline for research for future treatment. When the disease isn't identified until later in its progression, patients are more effective and treatments are even less impaired, doctors said. Current therapies usually don't make much difference, doctors acknowledged in a media briefing Monday.

Study: Popular Alzheimer's ineffective drug for mild cases

"It's critically important when we have effective drugs to intervene as quickly as possible," said Marilyn Albert, professor of neurology at Johns Hopkins University School of Medicine, who helped formulate the new guidelines. "there could be drugs available now, but we re using them too late in the disease course."

"the goal in the field is to find people earlier, so when new treatments are developed, we can use them."

The new guidelines appear Tuesday in the journal Alzheimer's & Dementia.

The original criteria for Alzheimer s disease, written in 1984, defined the disease in a single stage and assumed people who didn't have symptoms did not have the disease. This original definition addressed only later stages of the disease, when it ravages the patient's ability to function.

When Alzheimer's turns violent

The newly expanded stages of Alzheimer's are meant to cover the full spectrum of the disease as it first over the years.

"For people working with Alzheimer's patients day-to-day, it doesn't make a huge difference in practice right now," said Dr. Neil Kremen, unit chief at the Geriatric Psychiatry Inpatient Unit at Zucker Hillside Hospital in New York.

Most doctors working with Alzheimer's have already accepted that the disease is a progression.

"people who work in the field have known this," he said about various stages of Alzheimer's. "it has been accepted." It was never codified into a standard guideline. "In some sense, it's the formalization of things that people already know."

The courses have been divided into preclinical Alzheimer's, mild cognitive impairment and dementia.

First stage: Preclinical Alzheimer's disease

This internship is for research purposes only and will have no effect in your doctor's office.

The idea is that patients could be developing Alzheimer's, even when they are free of cognitive or memory problems.

This course is to help researchers determine whether there is a biological change caused by Alzheimer's that can be detected through blood, spinal fluid test or neuroimaging. Right now, there is no test that accurately predict whether a person will develop Alzheimer's disease.

With love and fear, Alzheimer's youngest caregivers watch over parents

While studies show that Alzheimer's patients experience changes in the brain - the buildup of amyloid protein tangles and nerve cell changes - it is unknown whether this means an inevitable progression to Alzheimer's dementia.

"Changes in their brain can be measured, but we can't predict for sure whether they're going to have the clinical disease," said Dr. Creighton Phelps, director of the Alzheimer's Disease Centers Program of the National Institutes of Health.

These tests are used only in research settings.

Scientists are working to develop a more definitive test or a scan to determine Alzheimer's risk.

Second stage: Mild cognitive impairment (MCI)

Long before a person gets an Alzheimer's diagnosis, he or she may show small changes in memory, behavior and thinking. This is called mild cognitive impairment.

Aging work force means dementia on the job could rise

While it does not cripple a person's ability to function throughout the day, these differences are often noticed by friends and family members.

Some patients in this stage are already observed by their doctors as "probable Alzheimer's."

This is a gray area because not all memory problems are Alzheimer's - related. Cognitive difficulties could stem from other factors such as a drug's side effects or vascular disease.

This stage could be used in specialized Alzheimer's clinics. A specialist might determine that the cognitive problems are caused by underlying Alzheimer's disease after a comprehensive exam, based on the disease process and symptoms, said Dr. John c. Morris, director and principal investigator of the Alzheimer's Disease Research Center at the Washington University School of Medicine.

But there are no blood or medical tests available in doctors' offices to confirm whether the mild cognitive impairment is because of Alzheimer's.

Third stage: because of Alzheimer's Dementia

This is the stage when memory, thinking and behavioral symptoms have become so damaging that the patient's ability to function is hindered.

The disease is not solely restricted to memory problems. The new guidelines include other symptoms such as difficulty finding words, visual and spatial problems, impaired reasoning and judgment.

This is the stage that people are most familiar with. The patient eventually becomes unable to carry out basic daily tasks - eating, bathroom-related functions and is fully dependent on others for basic care.

The purpose of setting out these updated stages of Alzheimer's is aimed at the future, Creighton said, to "define a research strategy for people who may be at risk for Alzheimer's."